Antihypertensive agent

The term 'Antihypertensive agent' refers to a broad and heterogeneous category of pharmacological compounds used to treat hypertension and manage elevated systemic blood pressure. It is not a single molecular target or receptor; rather, it represents multiple drug classes that act upon various physiological systems to reduce cardiovascular risk (StatPearls, 2023). Key molecular targets within this category include the angiotensin-converting enzyme (ACE), angiotensin II type 1 (AT1) receptors, beta-adrenergic receptors, and L-type calcium channels (NIH, 2023). By modulating these pathways, antihypertensive agents facilitate vasodilation, reduce cardiac workload, or decrease blood volume, thereby lowering the pressure exerted against arterial walls. Clinical management of hypertension using these agents is essential for preventing long-term complications such as stroke, myocardial infarction, heart failure, and end-stage renal disease (AHA, 2022). Because 'Antihypertensive agent' is a functional classification of drugs and not a specific biological molecule, it is considered an incorrect entry for a specific therapeutic target database.

Other names

Antihypertensive drugHypotensive agentBlood pressure lowering medication

Antihypertensive agents work through various mechanisms including the inhibition of the renin-angiotensin-aldosterone system (RAAS), blockade of L-type calcium channels to induce vasodilation, antagonism of beta-adrenergic receptors to reduce heart rate and contractility, and promotion of diuresis to reduce intravascular volume (StatPearls, 2023; NIH, 2023).